2014
DOI: 10.1016/j.actbio.2013.09.037
|View full text |Cite
|
Sign up to set email alerts
|

Biocompatibility of silver nanoparticles and silver ions in primary human mesenchymal stem cells and osteoblasts

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

14
166
2
6

Year Published

2015
2015
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 246 publications
(188 citation statements)
references
References 38 publications
14
166
2
6
Order By: Relevance
“…Furthermore, the possibility of the biocompatibility of orthopedic implants being compromised by the cytotoxicity of AgNPs against osteoblasts and osteoclasts is a major concern. In a study conducted by Pauksch et al, 55 osteoblasts were found to have a higher susceptibility to toxicological effects of less than 5 nm sized AgNPs than osteoclasts. In this study, AgNPs at ~30 nm size released more Ag + then the larger AgNPs, alluding to a similar size selectivity as that of the RBC and AgNP interaction.…”
Section: Toxicitymentioning
confidence: 99%
“…Furthermore, the possibility of the biocompatibility of orthopedic implants being compromised by the cytotoxicity of AgNPs against osteoblasts and osteoclasts is a major concern. In a study conducted by Pauksch et al, 55 osteoblasts were found to have a higher susceptibility to toxicological effects of less than 5 nm sized AgNPs than osteoclasts. In this study, AgNPs at ~30 nm size released more Ag + then the larger AgNPs, alluding to a similar size selectivity as that of the RBC and AgNP interaction.…”
Section: Toxicitymentioning
confidence: 99%
“…Among these, silver nanoparticles (AgNPs) have become the focus of much research interest due to their unique optical, electrical and biological properties which offers a number of exciting potential applications in various fields including catalysis, electronics and biology (Prabhu and Poulose 2012). They possess an excellent biocompatibility and low toxicity (Pauksch et al 2014). Silver nanoparticles have been documented in the field of biomedical (Chaloupka et al 2010), drug delivery (Prow et al 2011), food industries (Chaudhry and Castle 2011), agriculture (Nair et al 2010), textile industries (Kelly and Johnston 2011), water treatment (Dankovich and Gray 2011), antioxidant (Niraimathi et al 2013), antimicrobial (Sankar et al 2013), anti-cancer (Boca et al 2011), cosmetics (Jain et al 2009), ointments (Murphy 2008) and larvicides (Roopan et al 2013).…”
Section: Introductionmentioning
confidence: 99%
“…10 Several reports have found that the potential toxic effect caused by NS occurred only at high concentrations, and incorporated NS into biomaterials probably reduce the toxicity of NS. [11][12][13] Consequently, it is available to incorporate an optimized concentration of NS into a material to prepare an antibacterial wound dressing without cytotoxicity.…”
mentioning
confidence: 99%
“…Therefore, these results indicated that the cytotoxicity of NS occurred at high concentration as previously described. 11,12 Because of effective antibacterial activity without observed cytotoxicity, PCL/NS1.0 was chosen as the optimized film for the next experiments. The abovementioned results also demonstrated that an optimized concentration of NS was successfully found as expected.…”
mentioning
confidence: 99%